Company Profile
SCC's Laboratory Information Systems Suite®
SCC's Genetics Information Systems Suite®
SCC's Blood Services Information Systems Suite®
SCC's Outreach Information Systems Suite®
SCC's Pathology Information Systems Suite™
SCC's Forensic Science Information Systems Suite™
SCC's Research Information Systems Suite™
Educational Services
SCC Soft Computer’s Blood Bank Product Receives Market Approval from the Food and Drug Administration
August 18, 2010
Clearwater, FL – SCC Soft Computer’s, SoftBank® II version 25.1 received market approval from the Food and Drug Administration (FDA).
SoftBank II version 25.1 has added features to increase productivity in the laboratory and comply with safety regulations. One safety feature recently added to the system is label verification, which allows for the verification of the ISBT labels that are generated during component modification. Users can see whether these labels are correct based on the unit information in the database. The SoftBank system will track the label verification as part of the unit record. This feature completes the workflow process for ISBT labeling for blood products.
“SCC is the leader in healthcare information technology. We have high standards for our products and develop them with the customer in mind. Receiving market approval from the Food and Drug Administration confirms our objective of meeting safety regulations,” said Gilbert Hakim, CEO, SCC Soft Computer. “I am confident that SCC and its blood bank product will remain a leader in this competitive industry.”
SoftBank II is a centralized transfusion service management system that combines previous high-performance functionality with exciting new features to provide a comprehensive, cost-effective centralized testing solution. The database management system offers, fast, direct linking between records and transactions. This dramatically increases levels of security and integrity when performing and documenting activities and events. As a major asset to the laboratory, SoftBank II provides critical safety functions throughout the system allowing the laboratory’s focus to remain on providing safe blood components, tissue, and derivative products to patients. For more information on SoftBank II, please contact Ellie Vahman, ellie@softcomputer.com or (727) 789-0100 extension 4052.
About SCC Soft Computer
SCC is at the forefront of laboratory, genetics, blood services, outreach, pharmacy, and radiology information systems software development and offers full suites of Web-enabled clinical information management system solutions. Since 1979, SCC Soft Computer has been meeting the needs of the healthcare industry by providing powerful, clinical information solutions to hospitals, large IDNs (integrated delivery networks), and laboratories.
Considered the largest LIS software production house in the world – with a workforce of over 1,500 professionals dedicated to LIS development – SCC has experience in accomplishing complex LIS implementations in large, multisite environments. SCC's flagship product, SoftLab, has been recognized as the market standard for its robust functionality and ease of instrument interfacing, including robotics.
Consistently ranked 1st in the MD Buyline survey, a comprehensive, vendor-independent database used by hospitals and other medical facilities during the capital planning and purchasing process, SCC outranks its competitors in all categories. SCC has also been recognized for its commitment to workforce training and leadership development and has been included in the Training Top 125 eight times in nine years. The Company’s 2010 ranking of 9th in the Top 125 was based on SCC’s focus on employee development, as well as its comprehensive onboarding program and custom development plans for learners.